title: Exercise exerts neuroprotective effects on Parkinson's disease model of rats.
abstract: Recent studies demonstrate that rehabilitation ameliorates physical and cognitive impairments of patients with stroke, spinal cord injury, and other neurological diseases and that rehabilitation also has potencies to modulate brain plasticity. Here we examined the effects of compulsive exercise on Parkinson's disease model of rats. Before 6-hydroxydopamine (6-OHDA, 20 microg) lesion into the right striatum of female SD rats, bromodeoxyuridine (BrdU) was injected to label the proliferating cells. Subsequently, at 24 h after the lesion, the rats were forced to run on the treadmill (5 days/week, 30 min/day, 11 m/min). As behavioral evaluations, cylinder test was performed at 1, 2, 3, and 4 weeks and amphetamine-induced rotational test was performed at 2 and 4 weeks with consequent euthanasia for immunohistochemical investigations. The exercise group showed better behavioral recovery in cylinder test and significant decrease in the number of amphetamine-induced rotations, compared to the non-exercise group. Correspondingly, significant preservation of tyrosine hydroxylase (TH)-positive fibers in the striatum and TH-positive neurons in the substantia nigra pars compacta (SNc) was demonstrated, compared to the non-exercise group. Additionally, the number of migrated BrdU- and Doublecortin-positive cells toward the lesioned striatum was increased in the exercise group. Furthermore, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor increased in the striatum by exercise. The results suggest that exercise exerts neuroprotective effects or enhances the neuronal differentiation in Parkinson's disease model of rats with subsequent improvement in deteriorated motor function.
authors.affiliation: Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Okayama, 700-8558, Japan.
authors.forename: Naoki
authors.initials: N
authors.lastname: Tajiri
authors.forename: Takao
authors.initials: T
authors.lastname: Yasuhara
authors.forename: Tetsuro
authors.initials: T
authors.lastname: Shingo
authors.forename: Akihiko
authors.initials: A
authors.lastname: Kondo
authors.forename: Wenji
authors.initials: W
authors.lastname: Yuan
authors.forename: Tomohito
authors.initials: T
authors.lastname: Kadota
authors.forename: Feifei
authors.initials: F
authors.lastname: Wang
authors.forename: Tanefumi
authors.initials: T
authors.lastname: Baba
authors.forename: Judith Thomas
authors.initials: JT
authors.lastname: Tayra
authors.forename: Takamasa
authors.initials: T
authors.lastname: Morimoto
authors.forename: Meng
authors.initials: M
authors.lastname: Jing
authors.forename: Yoichiro
authors.initials: Y
authors.lastname: Kikuchi
authors.forename: Satoshi
authors.initials: S
authors.lastname: Kuramoto
authors.forename: Takashi
authors.initials: T
authors.lastname: Agari
authors.forename: Yasuyuki
authors.initials: Y
authors.lastname: Miyoshi
authors.forename: Hidemi
authors.initials: H
authors.lastname: Fujino
authors.forename: Futoshi
authors.initials: F
authors.lastname: Obata
authors.forename: Isao
authors.initials: I
authors.lastname: Takeda
authors.forename: Tomohisa
authors.initials: T
authors.lastname: Furuta
authors.forename: Isao
authors.initials: I
authors.lastname: Date
mesh_terms: D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D001205:Ascorbic Acid; D001522:Behavior, Animal; D019208:Brain-Derived Neurotrophic Factor / Q000378:metabolism; D001973:Bromodeoxyuridine / Q000378:metabolism; D049109:Cell Proliferation; D003342:Corpus Striatum / Q000187:drug effects / Q000502:physiology; D004195:Disease Models, Animal; D000089622:Doublecortin Domain Proteins; D000089662:Doublecortin Protein; D005080:Exercise Test; D005260:Female; D051098:Glial Cell Line-Derived Neurotrophic Factors / Q000378:metabolism; D008869:Microtubule-Associated Proteins; D009068:Movement / Q000187:drug effects; D009479:Neuropeptides; D016627:Oxidopamine; D010302:Parkinson Disease, Secondary / Q000139:chemically induced / Q000473:pathology / Q000503:physiopathology / Q000534:rehabilitation*; D010805:Physical Conditioning, Animal / Q000379:methods*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012399:Rotation; D013378:Substantia Nigra / Q000187:drug effects / Q000503:physiopathology; D013997:Time Factors; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
chemical_list: D019208:Brain-Derived Neurotrophic Factor; C000714848:Dcx protein, rat; D000089622:Doublecortin Domain Proteins; D000089662:Doublecortin Protein; D051098:Glial Cell Line-Derived Neurotrophic Factors; D008869:Microtubule-Associated Proteins; D009479:Neuropeptides; D016627:Oxidopamine; D000661:Amphetamine; D014446:Tyrosine 3-Monooxygenase; D001973:Bromodeoxyuridine; D001205:Ascorbic Acid